Recently, a study found that melatonin promoted the infiltration of N1 subtype neutrophils by CXCL2, which killed pancreatic cancer cells by NET-derived ROS, indicating the antitumor effect of NETs [75]. This evidence concerns the gene CXCL2 and pancreatic neoplasm.